banner
Pawg khoom
Tiv tauj peb

Hu rau:Errol Zhou (Mr.)

Tel: ntxiv 86-551-65523315

Mobile/WhatsApp: ntxiv 86 17705606359

QQ:196299583

Skype:lucytoday@hotmail.com

Email:sales@homesunshinepharma.com

Ntxiv:1002, Huanmao Tsev, No.105, Mengcheng Txoj kev, Hefei Lub zos, 230061 Tuam Tshoj

APIs thiab Intermediates
Omarigliptin CAS 1226781-44-7

Omarigliptin CAS 1226781-44-7

CAS TSIS TAU: 1226781-44-7
Cov Qauv Nqaij: C17H20F2N4O3S
Molecular Luj: 398.428
EINECS TSIS MUAJ: 682-558-0
MDL TSIS TAU: MFCD22573261

Txhawb tshuaj

Khoom Qhia:

Khoom npe: Omarigliptin CAS TSIS TAU: 1226781-44-7

Txhais:

MK-3102;

(2R, 3S, 5R) -2- (2,5-difluorophenyl) -5- [2- (methylsulfonyl) -2,6-dihydropyrrolo [3,4-c] pyrazol-5 (4H) -yl] -tetrahydro -2H-pyran-3-amine;

Tshuaj& Cov Khoom Uas Lub Cev:

Zog: Cov hmoov dawb dawb

Ntsuas: ≥99.0%

Qhov ceev: 1.6 g / cm3

Lub Ntsiab Kub: 529.4 ℃ ntawm 760 mmHg

Flash Point: 274.0 ± 32.9 ℃

Augagliptin (MK-3102) yog ib qho kev tiv thaiv kabmob uas ua haujlwm ntev dipeptidyl peptidase-4 (DPP-4) inhibitor, lub qhov ncauj hypoglycemic tus neeg sawv cev tsim los ntawm Merck& Co., ib zaug ib asthiv. Nws tuaj yeem tsim DPP txuas ntxiv. -4 Kev Tiv Thaiv, muaj cov roj ntsha ua rau cov ntshav qab zib kom tsawg dua, thiab muaj qhov zoo ntawm qhov tsis nce phaus, tsis ua rau kom mob ntshav qab zib, thiab tsis ua rau edema. Lub tshuab ntawm kev ua yog los ntawm inhibiting qhov kev ua kom zoo ntawm glucagon-zoo li peptide-1 (GLP-1) los ntawm DPP-4 enzyme hauv lub cev, ua kom ntev li lub sijhawm ua haujlwm ntawm GLP-1, yog li nce qhov endogenous GLP-1 thiab GIP hauv ntshav Concentration, thiab thaum kawg txhim kho ntshav qab zib kom tswj.

Yog tias koj txaus siab rau peb cov khoom lossis muaj lus nug, thov hu rau peb!

Cov khoom lag luam hauv qab patent yog muab rau R& D lub hom phiaj nkaus xwb. Txawm li cas los xij, lub luag haujlwm kawg tau txiav txim siab nrog cov neeg yuav khoom.


Cim npe nrov: omarigliptin cas 1226781-44-7, tuam ntxhab, lwm tus neeg, Hoobkas, yuav, hauv Tshuag

Xa kev nug